Vimarsana
Biggest News Aggregation in the World

Page 2 - Bioscience Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Division Today - Breaking & Trending Today

Zacks Investment Research Upgrades Grifols (NASDAQ:GRFS) to "Hold" - Vimarsana News

Zacks Investment Research Upgrades Grifols (NASDAQ:GRFS) to "Hold"

Grifols (NASDAQ:GRFS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous […]

Grifols (NASDAQ:GRFS) Upgraded to Hold at Zacks Investment Research - Vimarsana News

Grifols (NASDAQ:GRFS) Upgraded to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from a sell rating to a hold rating in a report issued on Friday morning, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic […]

Zacks Investment Research Upgrades Grifols (NASDAQ:GRFS) to Hold - Vimarsana News

Zacks Investment Research Upgrades Grifols (NASDAQ:GRFS) to Hold

Grifols (NASDAQ:GRFS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, […]

Grifols (NASDAQ:GRFS) Upgraded at Zacks Investment Research - Vimarsana News

Grifols (NASDAQ:GRFS) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from a sell rating to a hold rating in a report released on Friday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and […]

Grifols (NASDAQ:GRFS) Upgraded to "Hold" at Zacks Investment Research - Vimarsana News

Grifols (NASDAQ:GRFS) Upgraded to "Hold" at Zacks Investment Research

Zacks Investment Research upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from a sell rating to a hold rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and […]